Literature DB >> 25059461

Intentional examination of esophagus by narrow-band imaging endoscopy increases detection rate of cervical inlet patch.

C-S Chung1,2, C-K Lin1, C-C Liang1, W-F Hsu1, T-H Lee1.   

Abstract

Foci of heterotopic gastric mucosa have been identified at different sites in the human body and the most common location is the proximal esophagus which is referred to as cervical inlet patch (CIP). The true prevalence of CIP varies and it is usually incidental findings during endoscopy. Because CIP is always asymptomatic, it was believed to be of little clinical relevance. However, emerging studies have described the acid-secreting characteristics of heterotopic gastric mucosa and associations of CIP with gastroesophageal reflux disease (GERD). In addition, complications such as stricture, fistula, infection, mucosal hyperplasia, and malignant transformation have been reported. In this study, we investigated the prevalence of CIP, its associations with clinical manifestations, and the effect of intentional screening upper esophagus by magnifying endoscopy-narrow-band imaging (ME-NBI) system. Consecutive healthy adults who underwent panendoscopy were separated into two groups. Patients in group I (n = 471) were examined by an endoscopist who intended to find CIPs by ME-NBI. Patients in group II (n = 428) were examined by two endoscopists who were unaware of the study and performed white-light imaging endoscopy. Participants provided questionnaires on GERD-related symptoms. Higher CIP prevalence (11.7% vs. 1.9%, P < 0.0001) and longer duration of esophageal examination (mean ± standard deviation, 17.50 ± 12.40 vs. 15.24 ± 10.78 seconds, P = 0.004) were noted in group I than in group II. Analyzing group I patients revealed the higher prevalences of reflux symptoms (32.7% vs. 18.3%, P = 0.013) and erosive esophagitis (43.6% vs. 25.5%, P = 0.005) in patients with CIP than in those without. CIP was not associated with globus or dysphagia symptoms. More small CIPs (< 5 mm) were detected by ME-NBI than by white-light imaging (85.3% vs. 41.4%, P = 0.001). In conclusion, CIP prevalence was not low under intentional ME-NBI examination of the upper esophagus. The clinical relevance of CIP and its association with GERD require further investigation.
© 2014 International Society for Diseases of the Esophagus.

Entities:  

Keywords:  cervical inlet patch; gastroesophageal reflux disease; heterotopic gastric mucosa; narrow-band imaging

Mesh:

Year:  2014        PMID: 25059461     DOI: 10.1111/dote.12252

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  5 in total

1.  Cervical inlet patch: an important cause of Globus pharyngeus.

Authors:  Vui Heng Chong
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-18       Impact factor: 2.503

2.  Heterotopic Gastric Mucosa in the Proximal Esophagus: Prospective Study and Systematic Review on Relationships with Endoscopic Findings and Clinical Data.

Authors:  Marcin Romańczyk; Krzysztof Budzyń; Tomasz Romańczyk; Magdalena Lesińska; Mateusz Koziej; Marek Hartleb; Marek Waluga
Journal:  Dysphagia       Date:  2022-07-09       Impact factor: 3.438

Review 3.  Monitoring the premalignant potential of Barrett's oesophagus'.

Authors:  David Graham; Gideon Lipman; Vinay Sehgal; Laurence B Lovat
Journal:  Frontline Gastroenterol       Date:  2016-05-05

4.  Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS).

Authors:  Sabina Beg; Krish Ragunath; Andrew Wyman; Matthew Banks; Nigel Trudgill; D Mark Pritchard; Stuart Riley; John Anderson; Helen Griffiths; Pradeep Bhandari; Phillip Kaye; Andrew Veitch
Journal:  Gut       Date:  2017-08-18       Impact factor: 23.059

5.  The prevalence of gastric heterotopia of the proximal esophagus is underestimated, but preneoplasia is rare - correlation with Barrett's esophagus.

Authors:  Ulrich Peitz; Michael Vieth; Matthias Evert; Jovana Arand; Albert Roessner; Peter Malfertheiner
Journal:  BMC Gastroenterol       Date:  2017-07-12       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.